CIK 0001108205
- Non-accelerated filer
- Smaller reporting company
CURIS INC
Sign in to watch- Ticker
- CRIS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043505116
- Phone
- +1 617-503-6500
- Business address
- 128 SPRING STREET, BUILDING C, SUITE 500, LEXINGTON, MA, 02421
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy President & COO bought 3,000 shares at $2.52 ($7,560)
- 4 Open-market buy CFO bought 10,000 shares at $2.86 ($28,600)
- 4 Open-market buy Director bought 20,000 shares at $2.95 ($59,000)
- 4 Open-market buy Director bought 10,000 shares at $4.37 ($43,691)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 50,000 shares at $4.00 ($200,000)
- 4 Gift CFO gave 6,000 shares (gift)
- 4 Open-market sale CEO and Director sold 126,852 shares at an average $3.68 ($466,552)
- 4/A Open-market sale CEO and Director sold 175,000 shares at an average $3.69 ($645,050)
- 4 Exercise or conversion CFO acquired 50,000 shares (option exercise)
- 4 Exercise or conversion Director acquired 62,500 shares (option exercise)
- 4 Open-market sale CEO and Director sold 175,000 shares at an average $3.69 ($645,050)
Page 10 of 24 · 475 filings